In the BioHarmony Drug Report Database

"Preview" Icon

Dofetilide

Tikosyn (dofetilide) is a small molecule pharmaceutical. Dofetilide was first approved as Tikosyn on 1999-10-01. It is used to treat atrial fibrillation, atrial flutter, and cardiac arrhythmias in the USA. The pharmaceutical is active against potassium voltage-gated channel subfamily H member 2. In addition, it is known to target potassium voltage-gated channel subfamily H member 1.

 

Trade Name

 

Tikosyn
 

Common Name

 

dofetilide
 

ChEMBL ID

 

CHEMBL473
 

Indication

 

atrial fibrillation, atrial flutter, cardiac arrhythmias
 

Drug Class

 

Class III antiarrhythmic agents

Image (chem structure or protein)

Dofetilide structure rendering